Tempus Ai Share Price (NASDAQ: TEM)

$73.8

▲

2.21

(3.09%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Tempus Ai Stock chart to analyse performance

Tempus Ai stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$70.37
Today's High:$75.56
$73.80
4.65%
Downside
Day's Volatility :6.87%
Upside
2.33%
52 Weeks Low:$31.36
52 Weeks High:$91.45
$73.80
57.51%
Downside
52 Weeks Volatility :65.71%
Upside
19.3%

Tempus Ai Stock Returns

Period	Tempus Ai	Index (Russel 2000)
3 Months	15.75%	0.0%
6 Months	-9.97%	0.0%
1 Year	28.07%	0.0%
3 Years	83.3%	-11.6%

Tempus Ai Key Stats

Check Tempus Ai key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$71.59
Open	$71.97
Today's High	$75.56
Today's Low	$70.37
Market Capitalization	$11.5B
Today's Volume	$14.6M
52 Week High	$91.45
52 Week Low	$31.36
Revenue TTM	$952.0M
EBITDA	$-162.1M
Earnings Per Share (EPS)	$2.15
PE Ratio	30.86
Profit Margin	-20.98%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-97.95%

Stock Returns calculator for Tempus Ai Stock including INR - Dollar returns

The Tempus Ai stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tempus Ai investment value today

Current value as on today

₹1,32,313

Returns

₹32,313

(+32.31%)

Returns from Tempus Ai Stock

₹28,103 (+28.1%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Tempus Ai Stock

86.94%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Investment in Tempus Ai Shares from India has grown by 86.94% over the past 30 days, indicating increased transactional activity.

77%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Tempus Ai Stock from India on INDmoney has increased by 77% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Tempus Ai Stock

Rating

Trend

Tempus Ai Share Price Target

What analysts predicted

Downside of 5.83%

Target:

$69.50

Current:

$73.80

Tempus Ai share price target is $69.50, a slight Downside of 5.83% compared to current price of $73.80 as per analysts' prediction.

Tempus Ai Stock Insights

Price Movement
In the last 7 days, TEM stock has moved up by 21.3%
TEM vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 82.3% return, outperforming this stock by 37.3%
Price to Sales
ForTEM every $1 of sales, investors are willing to pay $13.1, whereas for Doximity, Inc., the investors are paying $20.7 for every $1 of sales.

Tempus Ai Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$62.1M	-
Net Income	$-148.1M	-
Net Profit Margin	-238.72%	-

	FY20	Y/Y Change
Revenue	$188.0M	↑ 202.95%
Net Income	$-209.9M	↑ 41.66%
Net Profit Margin	-111.62%	↑ 127.1%

	FY21	Y/Y Change
Revenue	$257.9M	↑ 37.15%
Net Income	$-259.2M	↑ 23.51%
Net Profit Margin	-100.52%	↑ 11.1%

	FY22	Y/Y Change
Revenue	$320.7M	↑ 24.36%
Net Income	$-289.8M	↑ 11.81%
Net Profit Margin	-90.38%	↑ 10.14%

	FY23	Y/Y Change
Revenue	$531.8M	↑ 65.85%
Net Income	$-214.1M	↓ 26.12%
Net Profit Margin	-40.26%	↑ 50.12%

	FY24	Y/Y Change
Revenue	$693.4M	↑ 30.38%
Net Income	$-705.8M	↑ 229.64%
Net Profit Margin	-101.79%	↓ 61.53%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$145.8M	↓ 1.29%
Net Income	$-64.7M	↑ 28.25%
Net Profit Margin	-44.4%	↓ 10.23%

	Q2 FY24	Q/Q Change
Revenue	$166.0M	↑ 13.82%
Net Income	$-552.2M	↑ 752.93%
Net Profit Margin	-332.72%	↓ 288.32%

	Q3 FY24	Q/Q Change
Revenue	$180.9M	↑ 9.01%
Net Income	$-75.8M	↓ 86.27%
Net Profit Margin	-41.92%	↑ 290.8%

	Q4 FY24	Q/Q Change
Revenue	$200.7M	↑ 10.92%
Net Income	$-13.0M	↓ 82.84%
Net Profit Margin	-6.48%	↑ 35.44%

	Q1 FY25	Q/Q Change
Revenue	$255.7M	↑ 27.44%
Net Income	$-68.0M	↑ 422.8%
Net Profit Margin	-26.6%	↓ 20.12%

	Q2 FY25	Q/Q Change
Revenue	$314.6M	↑ 23.03%
Net Income	$-42.8M	↓ 37.03%
Net Profit Margin	-13.62%	↑ 12.98%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$16.0M	-

	FY20	Y/Y Change
Profit	$22.8M	↑ 42.31%

	FY21	Y/Y Change
Profit	$77.4M	↑ 238.99%

	FY22	Y/Y Change
Profit	$121.7M	↑ 57.23%

	FY23	Y/Y Change
Profit	$286.2M	↑ 135.18%

	FY24	Y/Y Change
Profit	$381.1M	↑ 33.17%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$74.8M	↓ 8.26%

	Q2 FY24	Q/Q Change
Profit	$72.4M	↓ 3.23%

	Q3 FY24	Q/Q Change
Profit	$102.8M	↑ 41.97%

	Q4 FY24	Q/Q Change
Profit	$122.1M	↑ 18.77%

	Q1 FY25	Q/Q Change
Profit	$155.2M	↑ 27.15%

	Q2 FY25	Q/Q Change
Profit	$214.9M	↑ 38.45%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-117.1M	-
Investing Cash Flow	$-43.0M	-
Financing Cash Flow	$196.7M	-

	FY20	Y/Y Change
Operating Cash Flow	$-206.6M	↑ 76.38%
Investing Cash Flow	$-13.4M	↓ 68.82%
Financing Cash Flow	$506.1M	↑ 157.31%

	FY21	Y/Y Change
Operating Cash Flow	$-212.0M	↑ 2.62%
Investing Cash Flow	$-21.7M	↑ 61.93%
Financing Cash Flow	$-2.0M	↓ 100.4%

	FY22	Y/Y Change
Operating Cash Flow	$-168.2M	↓ 20.65%
Investing Cash Flow	$-57.9M	↑ 166.71%
Financing Cash Flow	$251.4M	↓ 12429.13%

	FY23	Y/Y Change
Operating Cash Flow	$-214.3M	↑ 27.43%
Investing Cash Flow	$-40.3M	↓ 30.42%
Financing Cash Flow	$117.5M	↓ 53.24%

	FY24	Y/Y Change
Operating Cash Flow	$-189.0M	↓ 11.8%
Investing Cash Flow	$-130.4M	↑ 223.45%
Financing Cash Flow	$494.3M	↑ 320.54%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-101.4M	↑ 151.76%
Investing Cash Flow	$17.0M	↓ 406.4%
Financing Cash Flow	$-1.4M	↓ 101.75%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-97.1M	↓ 4.24%
Investing Cash Flow	$-8.0M	↓ 147.13%
Financing Cash Flow	$504.0M	↓ 36675.4%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$48.7M	↓ 150.13%
Investing Cash Flow	$-131.4M	↑ 1541.01%
Financing Cash Flow	$-8.1M	↓ 101.61%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-39.3M	↓ 180.66%
Investing Cash Flow	$-8.0M	↓ 93.94%
Financing Cash Flow	$-179.0K	↓ 97.8%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-105.6M	↑ 169.1%
Investing Cash Flow	$-375.8M	↑ 4620.15%
Financing Cash Flow	$293.0M	↓ 163810.61%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$44.2M	↓ 141.81%
Investing Cash Flow	$-9.5M	↓ 97.47%
Financing Cash Flow	$-293.0M	↓ 200.0%

Tempus Ai Technicals Summary

Sell

Neutral

Buy

Tempus Ai is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tempus Ai Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tempus Ai	27.22%	-9.97%	28.07%	83.3%	83.3%
Doximity, Inc.	8.15%	-16.42%	80.77%	97.3%	22.89%
Ge Healthcare Technologies Inc.	-1.01%	-20.79%	-14.24%	21.34%	21.34%
Veeva Systems Inc.	-0.14%	20.52%	44.44%	28.01%	5.15%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tempus Ai	30.86	30.86	NA	-0.78	-0.98	-0.12	NA	1.78
Doximity, Inc.	54.31	54.31	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.09	15.09	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	59.27	59.27	1.49	6.45	0.14	0.07	NA	38.11

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tempus Ai	NA	$11.5B	83.3%	30.86	-20.98%
Doximity, Inc.	Hold	$11.9B	22.89%	54.31	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.6B	21.34%	15.09	11.22%
Veeva Systems Inc.	Buy	$45.6B	5.15%	59.27	27.34%

About Tempus Ai

Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Organization	Tempus Ai
Employees	2400
CEO	Mr. Eric P. Lefkofsky J.D.
Industry	Miscellaneous

Key Management of Tempus Ai

Name	Title
Mr. Eric P. Lefkofsky J.D.	Co-Founder, CEO, President & Chairman
Mr. Ryan Fukushima	Chief Operating Officer
Mr. Andrew Polovin	Executive VP, General Counsel & Secretary
Mr. James Rogers	Chief Financial Officer
Mr. Ryan M. Bartolucci CPA	Chief Accounting Officer
Mr. Shane Colley	Chief Technology Officer
Dr. Kate A. Sasser Ph.D.	Chief Scientific Officer
Mr. Erik Phelps	Executive VP, Assistant Secretary and Chief Administrative & Legal Officer
Ms. Elizabeth Krutoholow	Vice President of Investor Relations & Competitive Intelligence
Ms. Patty Spiller	Chief Marketing Officer

Important FAQs about investing in TEM Stock from India :

What is Tempus Ai share price today?

Tempus Ai share price today is $73.80 as on August 16, 2025 at 1:29 AM IST at the close of the market. Tempus Ai share today touched a day high of $75.56 and a low of $70.37.

What is the 52 week high and 52 week low for Tempus Ai share?

Tempus Ai share touched a 52 week high of $91.45 and a 52 week low of $31.36. Tempus Ai stock price today, August 16, 2025 at 1:29 AM IST is trending at $73.80, lower by 19.3% versus the 52 week high.

How to invest in Tempus Ai Stock (TEM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tempus Ai on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tempus Ai Shares that will get you 0.0203 shares as per Tempus Ai share price of $73.80 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Tempus Ai Stock (TEM) from India?

Indian investors can start investing in Tempus Ai (TEM) shares with as little as ₹87.492 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Tempus Ai stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Tempus Ai share’s latest price of $73.80 as on August 16, 2025 at 1:29 AM IST, you will get 0.1355 shares of Tempus Ai. Learn more about fractional shares .

What are the returns that Tempus Ai has given to Indian investors in the last 5 years?

Tempus Ai stock has given 83.3% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?